Quoin Pharmaceuticals, Ltd.
Stock Forecast, Prediction & Price Target
Quoin Pharmaceuticals, Ltd. Financial Estimates
Quoin Pharmaceuticals, Ltd. Revenue Estimates
Quoin Pharmaceuticals, Ltd. EBITDA Estimates
Quoin Pharmaceuticals, Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $15.57M Low: $15.57M High: $15.57M avg. 0% | Avg: $9.59M Low: $9.59M High: $9.59M avg. -38.39% | Avg: $79.79M Low: $79.79M High: $79.79M avg. 731.55% | Avg: $60.97M Low: $60.97M High: $60.97M avg. -23.58% |
Net Income
% change YoY
| $-8.51M N/A | $-9.27M -8.90% | $-8.68M 6.36% | Avg: $-11.15M Low: $-1.23M High: $-450.46K avg. -28.42% | Avg: $-7.71M Low: $-279.28K High: $-126.12K avg. 30.81% | Avg: $932.45K Low: $932.45K High: $932.45K avg. 112.08% | Avg: $2.09M Low: $2.09M High: $2.09M avg. 125.12% |
EBITDA
% change YoY
| $-20.26M N/A | $-8.74M 56.85% | $-9.27M -6.06% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$322.49 N/A | -$22.97 92.87% | -$9.64 58.03% | Avg: -$0.94 Low: -$1.37 High: -$0.5 avg. 90.30% | Avg: -$0.23 Low: -$0.31 High: -$0.14 avg. 75.93% | Avg: $1.04 Low: $1.04 High: $1.04 avg. 560% | Avg: $2.33 Low: $2.33 High: $2.33 avg. 125.12% |
Operating Expenses
% change YoY
| $6.06M N/A | $9.25M 52.69% | $9.37M 1.30% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Quoin Pharmaceuticals, Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 59.89% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -1.23M, average is -11.15M and high is -450.46K.
What is Quoin Pharmaceuticals, Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 167.39% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $15.57M, average is $15.57M and high is $15.57M.
What is Quoin Pharmaceuticals, Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 212.83% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.37, average is -$0.94 and high is $-0.5.